Investigating Eye-Movement Biomarkers of Disease Severity and Cognition in Multiple Sclerosis

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2023
The overarching goal of this research protocol is to acquire eye-tracking, cognitive, and disease-severity metrics in multiple sclerosis (MS) patients to further build up a database of MS patients and train a machine learning classifying algorithms to identify which eye-tracking metrics-or combination thereof-can serve as reliable markers of MS disease severity and cognitive status.
Epistemonikos ID: a5c0af28bf15f14c38b28737a4da84a99f16d8ab
First added on: May 14, 2024